United States (US) Rare Biomarkers Specimen Collection and Stabilization Market (2025-2031) | Value, Segmentation, Companies, Growth, Forecast, Outlook, Trends, Analysis, Share, Size & Revenue, Competitive Landscape, Industry

Name: United States (US) Rare Biomarkers Specimen Collection and Stabilization Market (2025-2031) | Value & Segmentation
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles), By Product (Isolation Kits and Reagents, Blood Collection Tubes, Systems), By Specimen (Serum/Plasma, Others), By Nucleic Acid and other Biomolecules (RNA, DNA, Others), By Application (NIPT, Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Dieases, Others), By End use (Hospitals, Perinatal Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Others) And Competitive Landscape

Product Code: ETC9974981	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Outlook
Market Size of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, 2024
Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Revenues & Volume for the Period 2021- 2031
United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Trend Evolution
United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Drivers and Challenges
United States (US) Rare Biomarkers Specimen Collection and Stabilization Price Trends
United States (US) Rare Biomarkers Specimen Collection and Stabilization Porter's Five Forces
United States (US) Rare Biomarkers Specimen Collection and Stabilization Industry Life Cycle
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Circulating Cell Free DNA (ccfDNA) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Circulating Tumor Cells (CTCs) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Exosomes/Extracellular Vesicles for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Isolation Kits and Reagents for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Blood Collection Tubes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Systems for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Specimen for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Serum/Plasma for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Nucleic Acid and other Biomolecules for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By RNA for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By DNA for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By NIPT for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Transcriptomics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Pharmacogenomics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Transplant Rejection for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Population Screening for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Cardiovascular Dieases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By End use for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Perinatal Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Public Health Labs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Private or Commercial Labs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Physician Labs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Research Institutes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Rare Biomarkers Specimen Collection and Stabilization Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Product
Market Opportunity Assessment By Specimen
Market Opportunity Assessment By Nucleic Acid and other Biomolecules
Market Opportunity Assessment By Application
Market Opportunity Assessment By End use
United States (US) Rare Biomarkers Specimen Collection and Stabilization Top Companies Market Share
United States (US) Rare Biomarkers Specimen Collection and Stabilization Competitive Benchmarking By Technical and Operational Parameters
United States (US) Rare Biomarkers Specimen Collection and Stabilization Company Profiles
United States (US) Rare Biomarkers Specimen Collection and Stabilization Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle

3.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces

3.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F

3.8 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F

3.9 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F

3.10 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies utilizing rare biomarkers

4.2.2 Growing prevalence of rare diseases and the need for accurate specimen collection and stabilization techniques

4.2.3 Technological advancements in specimen collection and stabilization methods improving efficiency and accuracy

4.3 Market Restraints

4.3.1 High costs associated with rare biomarker specimen collection and stabilization technologies

4.3.2 Stringent regulatory requirements and quality control standards for handling rare biomarkers

4.3.3 Limited awareness and adoption of advanced specimen collection and stabilization techniques

5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Trends

6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Types

6.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F

6.1.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F

6.1.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F

6.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Product

6.2.1 Overview and Analysis

6.2.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F

6.2.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F

6.2.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F

6.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen

6.3.1 Overview and Analysis

6.3.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F

6.3.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules

6.4.1 Overview and Analysis

6.4.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F

6.4.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F

6.4.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By Application

6.5.1 Overview and Analysis

6.5.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F

6.5.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F

6.5.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F

6.5.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F

6.5.6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F

6.5.7 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F

6.5.8 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F

6.5.9 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F

6.6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, By End use

6.6.1 Overview and Analysis

6.6.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F

6.6.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F

6.6.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F

6.6.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F

6.6.6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F

6.6.7 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F

7 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics

7.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries

7.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries

8 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators

8.1 Rate of adoption of new specimen collection and stabilization technologies

8.2 Number of research studies utilizing rare biomarkers for personalized medicine

8.3 Success rate of specimen collection and stabilization techniques in preserving rare biomarkers

9 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment

9.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F

9.4 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F

9.5 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F

9.6 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape

10.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024

10.2 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Rare Biomarkers Specimen Collection and Stabilization Market

Estonia Rare Biomarkers Specimen Collection and Stabilization Market

Ethiopia Rare Biomarkers Specimen Collection and Stabilization Market

Fiji Rare Biomarkers Specimen Collection and Stabilization Market

Finland Rare Biomarkers Specimen Collection and Stabilization Market

Gabon Rare Biomarkers Specimen Collection and Stabilization Market

Global Rare Biomarkers Specimen Collection and Stabilization Market

Middle East Rare Biomarkers Specimen Collection and Stabilization Market

North America Rare Biomarkers Specimen Collection and Stabilization Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here